CHIMIA
Not a member yet
8905 research outputs found
Sort by
The First Decade of Colloidal Lead Halide Perovskite Quantum Dots (in our Laboratory)
Get PDFTen years after the discovery of colloidal lead halide perovskite nanocrystals (LHP NCs), the field has witnessed substantial progress in synthetic methods, understanding of their surface chemistry and unique optical properties, precise control over NC size, shape, and composition. Ligand engineering, particularly with cationic and zwitterionic head groups, massively enhanced NC stability, compatibility with organic solvents, and photoluminescence efficiency. These breakthroughs allowed for the self-assembly of monodisperse NCs into complex long-range ordered superlattices and enabled the exploration of collective optical phenomena, such as superfluorescence. The development of low-cost scalable approaches like microfluidic systems and mechanochemical synthesis paved the way for the commercialization of LHP NCs, particularly for the down-conversion films in blue-backlit LCDs and as thermally-efficient color converters in pixelated displays. This review aims to trace the journey of these advancements, focusing on contributions from Switzerland, and outline future directions in this rapidly evolving field, such as quantum light sources, photocatalysis, etc
Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects
Get PDFThe endocannabinoid system (ECS) is a critical regulatory network composed of endogenous cannabinoids (eCBs), their synthesizing and degrading enzymes, and associated receptors. It is integral to maintaining homeostasis and orchestrating key functions within the central nervous and immune systems. Given its therapeutic significance, we have launched a series of drug discovery endeavors aimed at ECS targets, including peroxisome proliferator-activated receptors (PPARs), cannabinoid receptors types 1 (CB1R) and 2 (CB2R), and monoacylglycerol lipase (MAGL), addressing a wide array of medical needs. The pursuit of new therapeutic agents has been enhanced by the creation of specialized labeled chemical probes, which aid in target localization, mechanistic studies, assay development, and the establishment of biomarkers for target engagement. By fusing medicinal chemistry with chemical biology in a comprehensive, translational end-to-end drug discovery strategy, we have expedited the development of novel therapeutics. Additionally, this strategy promises to foster highly productive partnerships between industry and academia, as will be illustrated through various examples
Simplifying Nitration Chemistry with Bench-stable Organic Nitrating Reagents
Get PDFNitro compounds play a crucial role in academia and industries, serving as building blocks for the synthesis of drugs, agrochemicals, and materials. Nitration, a fundamental process in organic synthesis, has undergone significant evolution since the 19th century. While electrophilic nitration dominates historically, recent decades have seen a focus on new reagents and their reactivity modes for achieving mild and robust synthesis of nitro compounds. Our group has a longstanding interest in developing cost-effective, readily available, recyclable nitrating reagents derived from organic scaffolds. These reagents serve as a controllable source of nitryl radical and nitronium ion species, enabling mild and practical nitration of hydrocarbons with exceptional functional group tolerance. This account details the development of nitrating reagents and their diverse applications in catalytic nitration across various classes of organic molecules